| [1] | Healy D (2004) Let them eat Prozac. New York: New York University Press. pp. 124–148. pp.
|
| [2] | Pfizer Canada (2004 May 26) Stronger warning for SSRIs and other newer antidepressants regarding the potential for behavioural and emotional changes, including risk of self-harm. Available: http://www.hc-sc.gc.ca/dhp-mps/medeff/ad？visories-avis/prof/2004/zoloft_2_hpc-cps？_e.html. Accessed 21 July 2006.
|
| [3] | Pfizer (2005 February) Zoloft prescribing information. Available: http://www.fda.gov/cder/foi/label/2005/0？19839s053S054lbl.pdf. Accessed 21 July 2006.
|
| [4] | Medicines and Healthcare Products Regulatory Agency (2004) Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitors. Available: http://www.mhra.gov.uk/home/idcplg?IdcSe？rvice=GET_FILE&dDocName=CON019472&Revisi？onSelectionMethod=LatestReleased. Accessed 21 July 2006.
|
| [5] | GlaxoSmithKline (2006) Paroxetine adult suicidality analysis: Major depressive disorder and non-major depressive disorder—Appendix 2. Available: http://www.gsk.com/media/par_current_ana？lysis.htm. Accessed 21 July 2006.
|
| [6] | Inman W, Kubota K, Pearce G, Wilton L (1993) P.E.M report number 6. Paroxetine. Pharmacoepidemiol Drug Saf 2: 393–422.
|
| [7] | Edwards JG, Inman WH, Wilton L, Pearce GL, Kubota K (1997) Drug safety monitoring of 12692 patients treated with fluoxetine. Hum Psychopharmacol 12: 127–137.
|
| [8] | Healy D (2000) Emergence of antidepressant induced suicidality. Prim Care Psychiatry 6: 23–28.
|
| [9] | Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, et al. (2003) Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. JAMA 290: 1033–1041.
|
| [10] | March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, et al. (1998) Sertraline in children and adolescents with OCD: A multicenter randomized controlled trial. JAMA 280: 1752–1758.
|
| [11] | Kuslak V (2003 August 22) Letter to physicians. Wyeth Pharmaceuticals.
|
| [12] | Medicines and Healthcare Products Regulatory Agency (2006) Adverse drug reactions online information tracking: Drug analysis print. Available: http://www.mhra.gov.uk/home/groups/publi？c/documents/sentineldocuments/dap_113023？6020641.pdf. Accessed 26 July 2006.
|
| [13] | Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK (1998) Adverse drug reactions. BMJ 316: 1295–1298.
|
| [14] | Medawar C, Herxheimer A, Bell A, Jofre S (2002) Paroxetine, Panorama and user reporting of ADRs: Consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int J Risk Saf Med 15: 161–169.
|
| [15] | Medawar C, Herxheimer A (2003) A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 16: 3–17.
|
| [16] | Healy D, Aldred G (2005) Antidepressant drug use and the risk of suicide. Int Rev Psychiatry 17: 163–172.
|
| [17] | Healy D, Whitaker CJ (2003) Antidepressants and suicide: Risk-benefit conundrums. J Psychiatry Neurosci 28: 331–339.
|
| [18] | Healy D, Savage M (1998) Reserpine exhumed. Brit J Psychiatry 172: 376–378.
|
| [19] | Cunningham Owens DG (1999) A guide to the extrapyramidal side-effects of antipsychotic drugs. Cambridge: Cambridge University Press.
|
| [20] | Duncan EJ, Adler LA, Stephanides M, Sanfilipo M, Angrist B (2000) Akathisia and exacerbation of psychopathology: A preliminary report. Clin Neuropharmacol 23: 169–173.
|
| [21] | American Psychiatric Association (2000) Diagnostic and statistical manual IV TR. Washington (D. C.): American Psychiatric Association.
|
| [22] | Lane RM (1998) SSRI-induced extrapyramidal side effects and akathisia: Implications for treatment. J Psychopharmacol 12: 192–214.
|
| [23] | Siris SG (1985) Three cases of akathisia and “acting out”. J Clin Psychiatry 46: 395–397.
|
| [24] | Herrera JN, Sramek JJ, Costa JF, Roy S, Heh CW, et al. (1988) High potency neuroleptics and violence in schizophrenia. J Nerv Ment Dis 176: 558–561.
|
| [25] | Schulte JR (1985) Homicide and suicide associated with akathisia and haloperidol. Am J Forensic Psychiatry 6: 3–7.
|
| [26] | Hoehn-Saric R, Lipsey JR, McLeod DR (1990) Apathy and indifference in patients on fluvoxamine and fluoxetine. J Clin Psychopharmacol 10: 343–345.
|
| [27] | Wilkinson D (1990) Loss of anxiety and increased aggression in a 15-year-old boy taking fluoxetine. J Psychopharmacol 13: 420.
|
| [28] | Garland EJ, Baerg EA (2001) Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. J Child Adolesc Psychopharmacol 11: 181–186.
|
| [29] | Barnhart WJ, Makela EH, Latocha MJ (2004) SSRI-induced apathy syndrome: A clinical review. J Psychiatr Pract 10: 196–199.
|
| [30] | Wilens TE, Biederman J, Kwon A, Chase R, Greenberg L, et al. (2003) A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 13: 143–152.
|
| [31] | Preda A, MacLean RW, Mazure CM, Bowers MB (2001) Antidepressant associated mania and psychosis resulting in psychiatric admission. J Clin Psychiatry 62: 30–33.
|
| [32] | Nakra BR, Szwabo P, Grossberg GT (1989) Mania induced by fluoxetine. Am J Psychiatry 146: 1515–1516.
|
| [33] | Hersh CB, Sokol MS, Pfeffer C (1991) Transient psychosis with fluoxetine. J Am Acad Child Adolesc Psychiatry 30: 851–852.
|
| [34] | Stoll AL, Mayer PV, Kolbrener M, Goldstein E, Suplit B, et al. (1994) Antidepressant-associated mania: A controlled comparison with spontaneous mania. Am J Psychiatry 151: 1642–1645.
|
| [35] | Narayan M, Meckler L, Nelson JC (1995) Fluoxetine-induced delusions in psychotic depression. J Clin Psychiatry 56: 329.
|
| [36] | Alao A, Yolles JC, Armenta WC, Dewan MJ (1991) Somnambulism precipitated by selective serotonin-reuptake inhibitors. J Pharm Technol 15: 204–207.
|
| [37] | Kawashima T, Yamada S (2003) Paroxetine-induced somnambulism. J Clin Psychiatry 64: 483.
|
| [38] | Rampling D (1978) Aggression: A paradoxical response to tricyclic antidepressants. Am J Psychiatry 135: 117–118.
|
| [39] | United States District Court of Wyoming (2001) Tobin v. SmithKline Beecham Pharmaceuticals. Fed Suppl 164: 1278.
|
| [40] | New South Wales Supreme Court (2001) Regina v. Hawkins. NSWSC 420: paragraph 66.
|
| [41] | Supreme Court of Western Australia (2004) State of Western Australia and B, Sentence, Transcript of Proceedings, Perth, May 26, 2004. 67 of 2004.
|
| [42] | Mendelson WB (1994) Sleepwalking associated with zolpidem. J Clin Psychopharmacol 14: 150.
|
| [43] | Harazin J, Berigan TR (1999) Zolpidem tartrate and somnambulism. Mil Med 164: 669–670.
|
| [44] | Baonza MY, Garcia-Borra JMF, Majada AC, Gonzalez RS (2003) [Somnambulism associated with zolpidem] [Article in Spanish]. Aten Primaria 32: 438.
|
| [45] | (2000) Hypnosedatives and anxiolytics. Meyler's side effects of drugs. 14th Edition. In: Dukes MNG, Aronson JK, editors. Amsterdam: Elsevier. pp. 121–138. pp.
|
| [46] | Supreme Court of Mississippi (2002) Bennett v. Madakasira. So. 2d 821: 794.
|
| [47] | 7th Circuit Court of Florida for St. Johns County (2006) State of Florida v. Leslie Demeniuk. Case Number CF-01–930.
|
| [48] | (2005) State of South Carolina v. Christopher Frank Pittman. Case Number 04-GS–12–571.
|
| [49] | Springer J (2005 February 16) Jurors find teenager guilty of murdering his grandparents. Court TV News. Available: http://www.courttv.com/trials/pittman/02？1505_verdict_ctv.html. Accessed 1 August 2006.
|
| [50] | (2005) State of South Carolina v. Christopher Frank Pittman. pp. 2467–2468. Case Number 04-GS-12–571. Trial transcript. pp.
|
